SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-052452 from Indaptus Therapeutics, Inc. (INDP)

Indaptus Therapeutics, Inc.
Date: Dec. 30, 2024 · CIK: 0001857044 · Accession: 0001493152-24-052452

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284026

Date
Dec. 30, 2024
Author
Chief
Form
CORRESP
Company
Indaptus Therapeutics, Inc.

Letter

Indaptus Therapeutics, Inc.

Columbus Circle

15th Floor

New York, NY 10019

December 30, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, DC 20549

RE: Indaptus Therapeutics, Inc. (CIK 0001857044)

Registration Statement No. 333-284026 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

Indaptus Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on December 31, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at +1-212-801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.

Very
truly yours,
Indaptus
Therapeutics, Inc.

Show Raw Text
CORRESP
1
filename1.htm

Indaptus
Therapeutics, Inc.

3
Columbus Circle

15th
Floor

New
York, NY 10019

December
30, 2024

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
DC 20549

    RE:
    Indaptus
    Therapeutics, Inc. (CIK 0001857044)

    Registration
    Statement No. 333-284026 on Form S-1 (the “Registration Statement”)

Ladies
and Gentlemen:

Indaptus
Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration
Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may
become effective on December 31, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel,
Greenberg Traurig, LLP, by calling Gary Emmanuel at +1-212-801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw
this request for acceleration.

    Very
    truly yours,

    Indaptus
    Therapeutics, Inc.

    By:
    /s/
    Nir Sassi

    Nir
    Sassi

    Chief
    Financial Officer